MedTrace Logo

The NeXT Study; The Netherlands XTC Toxicity Study

NCT00235768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2005-10-10

No results posted yet for this study

Summary

The purpose of this study is to investigate the possible neurotoxic effects of the party-drug Ecstasy (MDMA)on brain and brain function in humans. Main research questions concern the causality, course and clinical relevance of the neurotoxicity of ecstasy

Conditions

  • Ecstasy (Drug)
  • N-Methyl-3,4-Methylenedioxymethamphetamine
  • Psychopathology

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • University of Amsterdam, Bonger Institute of Criminology

    collaborator UNKNOWN

  • Erasmus Medical Center

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Wim van den Brink, MD PhD · University of Amsterdam, Academic Medical Center Amsterdam, Dep of Psychiatry

  • Nick F Ramsey, PhD · University Medical Center Utrecht, Dep of Psychiatry

  • Dirk J Korf, PhD · University of Amsterdam, Bonger Institute for Criminology

  • Maartje ML de Win, MD · University of Amsterdam, Academic Medical Center Amsterdam, Dep of Radiology

  • Gerry Jager, MSc · University Medical Center Utrecht, Dep of Psychiatry

  • Hylke KE Vervaeke, MSc · University of Amsterdam, Bonger Institute of Criminology

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-04-30
Completion
2005-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235768 on ClinicalTrials.gov